DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 3,690.00
+290.00 (8.53%)
Apr 1, 2026, 3:30 PM KST
DK Life Science Market Cap
DK Life Science has a market cap or net worth of 118.02 billion as of April 1, 2026. Its market cap has decreased by -30.90% in one year.
Market Cap
118.02B
Enterprise Value
149.75B
Revenue
130.34B
Ranking
n/a
PE Ratio
13.42
Stock Price
3,690.00
Market Cap Chart
Since February 17, 2025, DK Life Science's market cap has decreased from 200.38B to 118.02B, a decrease of -41.10%. That is a compound annual growth rate of -37.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 108.75B | -7.10% |
| Dec 30, 2025 | 117.06B | -41.58% |
| Feb 17, 2025 | 200.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.62T |
| Celltrion | 43.13T |
| Sam Chun Dang Pharm. | 19.28T |
| ALTEOGEN | 18.27T |
| Osang Healthcare Co.,Ltd | 120.46B |
| Ildong Holdings | 115.07B |
| Amicogen | 114.49B |
| CG Invites | 114.03B |